Variant-Specific IgA Protects Against Omicron Infection

Page view(s)
0
Checked on
Variant-Specific IgA Protects Against Omicron Infection
Title:
Variant-Specific IgA Protects Against Omicron Infection
Journal Title:
The Journal of Infectious Diseases
Publication Date:
24 November 2023
Citation:
Goh, Y. S., Fong, S.-W., Hor, P. X., Loh, C. Y., Wang, B., Salleh, S. N. M., Ngoh, E. Z. X., Lee, R. T. C., Poh, X. Y., Rao, S., Chia, P. Y., Ong, S. W. X., Lee, T. H., Lim, C., Teo, J., Pada, S., Sun, L. J., Ong, D. L. S., Somani, J., … Loo, L. H. (2023). Variant-Specific IgA Protects Against Omicron Infection. The Journal of Infectious Diseases, 230(2), e287–e291. https://doi.org/10.1093/infdis/jiad525
Abstract:
Abstract Background The emergence of rapidly evolving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, coupled with waning vaccine-induced immunity, has contributed to the rise of vaccine breakthrough infections. It is crucial to understand how vaccine-induced protection is mediated. Methods We examined 2 prospective cohorts of mRNA vaccinated and boosted individuals during the Omicron wave of infection in Singapore. Results We found that individuals who remain uninfected over the follow-up period had a higher variant-specific IgA, but not IgG, antibody response at 1 month after booster vaccination, compared with individuals who became infected. Conclusions We conclude that IgA may have a potential contributory role in protection against Omicron infection. Clinical Trials Registration . NCT05142319.
License type:
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Funding Info:
This research / project is supported by the Biomedical Research Council Singapore A*CRUSE vaccine monitoring project; Agency for Science, Technology and Research (A*STAR) A*ccelerate GAP project - NA
Grant Reference no. : ACCL/19-GAP064-R20H-H

This research / project is supported by the National Medical Research Council Singapore COVID-19 Research Fund - NA
Grant Reference no. : COVID19RF-001, COVID19RF-007, COVID19RF-0008, COVID19RF-0018, COVID19RF-060, OFLCG19May-0034

This research / project is supported by the US Food and Drug Administration - NA
Grant Reference no. : 75F40120C00085

This research / project is supported by the A*STAR COVID-19 research - NA
Grant Reference no. : H/20/04/g1/006

This research / project is supported by the A*STAR Career Development Fund - NA
Grant Reference no. : SC35/22-805100

This research / project is supported by the Medical Research Council Singapore COVID-19 Research - NA
Grant Reference no. : COVID19RF-0018
Description:
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com https://doi.org/10.1093/infdis/jiad525
ISSN:
0022-1899
1537-6613
Files uploaded: